Exfoliation Syndrome: Clinical Trials

3 trials for Exfoliation Syndrome, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 enrolling by invitation. 3 Phase 2, 1 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 23Completed 2, Enrolling by invitation 1
Phase 11Enrolling by invitation 1
Phase 31Completed 1

Follow Exfoliation Syndrome: new trials by email Literature Review of Exfoliation Syndrome trials Research Report on Exfoliation Syndrome

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Topical Insulin for Glaucoma (TING2)
EYED-002 Low Dose (721 U/mL topical insulin), EYED-002 High Dose (1442 U/mL topical insulin), EYED-002 (highest tolerated dose, 12-month) - Open Angle Glaucoma, Primary Open Angle Glaucoma
Phase 1 / Phase 2Enrolling by invitationStanford University902026-09-102026-10-13
A Prospective Study to Assess the Hypotensive Efficacy of Rho-Kinase Inhibitor AR-12286 Ophthalmic Solution 0.5% and 0.7% in Patients With Exfoliation Syndrome and Ocular Hypertension or Glaucoma
AR-12286 - Exfoliation Syndrome, Ocular Hypertension
Phase 2CompletedRobert Ritch, MD, LLC.102013-09-012018-11-16
Will the Use of Triesence During Glaucoma Surgery Provide Lower Eye Pressure and Improve the Results of the Surgery?
Triesence, balanced salt solution BSS - Glaucoma
Phase 2 / Phase 3CompletedWills Eye772009-02-012018-07-10

Narrower conditions

Glaucoma, Open-Angle (3)  ·  Glaucoma (2)  ·  Glaucoma, Angle-Closure (1)  ·  Glaucoma, Neovascular (1)  ·  Low Tension Glaucoma (1)  ·  Ocular Hypertension (1)

Broader conditions

Eye Diseases (3)  ·  Iris Diseases (3)  ·  Uveal Diseases (3)  ·  Ocular Hypertension (2)  ·  Glaucoma (1)  ·  Optic Nerve Diseases (1)

Interventions

AR-12286 (1)  ·  Hanks Balanced Salt Solution (1)  ·  Insulin (1)  ·  Triamcinolone (1)

Sponsors

Robert Ritch, MD, LLC. (1)  ·  Stanford University (1)  ·  Wills Eye (1)

Countries

United States (3)

Top investigators

Jeffrey L Goldberg, MD PhD (1)  ·  Marlene R Moster, MD (1)

Results publications

PMID 24794283